News for 'Drugs Administration'

UK follows Trump? Indian eateries in UK under lens for illegal immigrants

UK follows Trump? Indian eateries in UK under lens for illegal immigrants

Rediff.com10 Feb 2025

The UK Home Office has announced a crackdown on illegal working across the country, targeting restaurants, nail bars, convenience stores, and car washes. In January, Immigration Enforcement teams conducted record-breaking raids, arresting 609 individuals, a 73% increase from the previous year. The crackdown comes as the government introduces new legislation aimed at tackling criminal gangs that facilitate illegal immigration. The Home Office highlights the dangers of illegal migration and the exploitation of vulnerable individuals while emphasizing its commitment to safeguarding workers and removing foreign criminals.

Trump names Indian-American close aide Kash Patel as FBI chief

Trump names Indian-American close aide Kash Patel as FBI chief

Rediff.com1 Dec 2024

President-elect Donald Trump has nominated Kash Patel, a close confidante, as the Director of the Federal Bureau of Investigation (FBI). This appointment would make Patel the highest-ranking Indian American in Trump's incoming administration. Patel has previously served in various roles in the Trump administration, including Chief of Staff at the Department of Defense, Deputy Director of National Intelligence, and Senior Director for Counterterrorism at the National Security Council. Trump praised Patel's work in uncovering the "Russia, Russia, Russia Hoax" and his commitment to "bringing back Fidelity, Bravery, and Integrity to the FBI." Patel, who has extensive experience in law enforcement and national security, is known for his work on the Russia investigation and his criticism of the "deep state."

'BJP Will Come To Power In Kerala In 2026'

'BJP Will Come To Power In Kerala In 2026'

Rediff.com10 Apr 2025

'In today's political spectrum, it is the Bharatiya Janata Party that always says, nation first.'

12 Bengal docs suspended over expired IV fluid death case

12 Bengal docs suspended over expired IV fluid death case

Rediff.com16 Jan 2025

The West Bengal government has suspended 12 doctors of Midnapore Medical College and Hospital for negligence following the death of a woman and four others falling ill after childbirth. The incident is alleged to have been caused by the administration of 'expired' intravenous fluid. Chief Minister Mamata Banerjee announced a compensation of Rs 5 lakh and a government job to the family of the deceased woman.

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin recalls 9,210 bottles of anti-infective drug from the US

Rediff.com15 Apr 2014

The recent recalls come amid increased FDA scrutiny of medicines produced in India.

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Rediff.com9 Apr 2014

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments

USFDA pulls up Sun Pharma for lapses in Halol plant

USFDA pulls up Sun Pharma for lapses in Halol plant

Rediff.com14 Jan 2023

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant. In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products. "This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals... Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," the USFDA stated.

J-K: 5 cops, teacher sacked for narco-terror links

J-K: 5 cops, teacher sacked for narco-terror links

Rediff.com3 Aug 2024

The Jammu and Kashmir administration on Saturday sacked six government employees, including five policemen, for their 'deep involvement in anti-national activities', officials said.

USTR Report Intensifies Trade Tensions With India

USTR Report Intensifies Trade Tensions With India

Rediff.com2 Apr 2025

The US Trade Representative noted that India's average applied tariff rate stood at 17% per cent, the highest of any major world economy.

Tirupati laddu row: Food safety regulator notice to ghee supplier

Tirupati laddu row: Food safety regulator notice to ghee supplier

Rediff.com23 Sep 2024

The controversy has sparked reactions across states. The famous Mankameshwar temple in Uttar Pradesh has now banned offerings of 'prasad' bought by devotees from outside and said they can offer homemade 'prasad' or fruits.

India better placed than China in trade with US: Experts

India better placed than China in trade with US: Experts

Rediff.com6 Nov 2024

Donald Trump's Presidency of the United States will open new opportunities for India though certain sectors, especially pharma and IT, may face the heat if the incoming president decides to impose restrictions on imports and H1B visa regulations, experts said on Wednesday. Prime Minister Narendra Modi's friendly relationship with Trump will have a positive bearing on Indo-US relations but India may have to adapt its strategies to maintain cooperation in areas of mutual interest.

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Maha suspends licences of 6 cough syrup manufacturers for rule breach

Rediff.com4 Mar 2023

Rathod said the Maharashtra government had initiated an inquiry against 84 out of 108 manufacturers of cough syrups in the state.

'Murderers Are The Most Reliable People'

'Murderers Are The Most Reliable People'

Rediff.com19 Feb 2025

'It would be difficult for us to run jails if it wasn't for murderers.'

Lakshadweep administrator has Modi's ear, and trust

Lakshadweep administrator has Modi's ear, and trust

Rediff.com16 Jun 2021

Given Narendra Modi's trust in him, Praful Khoda Patel is unlikely to back down in Lakshadweep.

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Rediff.com24 May 2023

After reports of contamination in cough syrups sent from the country, India is considering a system to test them before exporting. It is learnt that the Central Drugs Standard Control Organisation (CDSCO) has sent a proposal to the Union health ministry on this. The idea is to test the medicines at government labs before exporting.

Indian-American Jay Bhattacharya to be Trump's health agency head

Indian-American Jay Bhattacharya to be Trump's health agency head

Rediff.com27 Nov 2024

US President-elect Donald Trump has nominated Indian-American scientist Jay Bhattacharya to lead the National Institutes of Health (NIH), the country's top health research and funding institutions. Bhattacharya, a professor of Health Policy at Stanford University, is known for his research on the health and well-being of vulnerable populations. Trump also nominated Jim O'Neill as the deputy secretary of Health and Human Services to work alongside Robert F. Kennedy Jr.

Lupin gets USFDA nod to market HIV drug in US

Lupin gets USFDA nod to market HIV drug in US

Rediff.com10 Dec 2013

The company has received final approval from the US Food and Drug Administration for its Abacavir Sulfate Lamivudine, and Zidovudine Tablets, Lupin Ltd said in a statement.

Notice to ayurvedic drugs firm for misleading Covid claims

Notice to ayurvedic drugs firm for misleading Covid claims

Rediff.com20 Apr 2021

The company claimed that its product is "three times better than remdesivir and that 'AAYUDH Advance starts where vaccines stop'."

FDA finds contaminated drug ingredient at GSK Ireland plant

FDA finds contaminated drug ingredient at GSK Ireland plant

Rediff.com2 Apr 2014

The FDA has stepped up its efforts to ensure drug safety in recent months.

US regulator tightens drug approval norms

US regulator tightens drug approval norms

Rediff.com29 Jul 2013

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics

Covovax as Covid booster jab to be available on CoWIN soon

Covovax as Covid booster jab to be available on CoWIN soon

Rediff.com10 Apr 2023

Covovax is likely to be available on the portal in a few days at a price of Rs 225 per dose plus applicable GST.

Pharma crusader takes India's drug regulators to court

Pharma crusader takes India's drug regulators to court

Rediff.com7 Mar 2016

Dinesh Thakur is famous for exposing Ranbaxy safety problems

Less competition, demand-supply gap push US drug prices

Less competition, demand-supply gap push US drug prices

Rediff.com13 Oct 2014

Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.

3 Indian pharma cos recall products in US market

3 Indian pharma cos recall products in US market

Rediff.com24 Apr 2022

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes. Similarly, Jubilant Cadista is recalling a drug which is used to treat different inflammatory conditions.

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Rediff.com22 Oct 2013

The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.

Trump picks anti-vaccine activist as health secretary

Trump picks anti-vaccine activist as health secretary

Rediff.com15 Nov 2024

President-elect Donald Trump announced a slate of key Cabinet nominations, including tapping former Democratic presidential candidate Robert F. Kennedy Jr. as his Secretary of Health and Human Services and former Congressman Doug Collins of Georgia as Secretary for Veterans Affairs. Trump also named Jay Clayton as US Attorney for the Southern District of New York, Todd Blanche as Deputy Attorney General, and Dean John Sauer as Solicitor General of the United States.

FSSAI launches probe into MDH and Everest products

FSSAI launches probe into MDH and Everest products

Rediff.com23 Apr 2024

The Food Safety and Standards Authority of India (FSSAI) has commissioned a quality check on MDH and Everest products. This follows complaints that several popular spice mixes of the two leading brands contained traces of ethylene oxide more than the permissible levels, official sources said. This move by FSSAI comes after Hong Kong and Singapore recalled variants of the two masala majors' products in their countries.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

UK's richest 10% took half of wealth from India during colonialism

UK's richest 10% took half of wealth from India during colonialism

Rediff.com20 Jan 2025

The United Kingdom extracted USD 64.82 trillion from India over a century of colonialism between 1765 and 1900 and USD 33.8 trillion of this went to the richest 10 per cent -- enough money to carpet London in notes of 50 British pound almost four times over.

Madhuri Dixit gets FDA notice for endorsing Maggi

Madhuri Dixit gets FDA notice for endorsing Maggi

Rediff.com29 May 2015

If the actress fails to respond to the notice within the stipulated time frame, a case could be registered against her, Food Security Officer Mahimanand Joshi said.

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Pharma stocks rally on lower price erosion, hopes of US generic mkt uptick

Rediff.com9 Jul 2023

The BSE Healthcare Index is up 19 per cent as compared to BSE Sensex returns of 11 per cent during this period. Nitin Agarwal of DAM Capital highlighted this trend in a report last month. "After a sustained period of underperformance over FY21-23, the BSE Healthcare Index has once again captured the spotlight. "The recent uptick in performance has been driven by hospitals and emerging green shoots in pharmaceutical exports, particularly to the US, along with sustaining momentum in domestic branded formulations," he said.

Local drug makers worried as regulators start working together

Local drug makers worried as regulators start working together

Rediff.com26 Dec 2013

Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.

Cancer Research Is Hampered By Lack Of Racial Data

Cancer Research Is Hampered By Lack Of Racial Data

Rediff.com2 May 2023

Cancer has no race, so why do new innovative cancer drugs discriminate based on race and ethnic groups, asks Digonto Chatterjee.

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Rediff.com29 Apr 2022

Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country for Indian players who already have an approved plant and product from one of the stringent regulatory authorities like US, EU or Canada. From current sales of $340 mn, the Indian firms can see a significant upside in sales; felt Dinesh Dua, former chairman of the Pharmaceutical Exports Promotion Council of India (Pharmexcil), and the MD of Nectar Lifesciences. He highlighted that only 12 percent of the Australian drug market is generic, as against 80-90 per cent in the US or EU. Of this $1.5 bn generic drug market in India, Indian companies have a small share.

Sun Pharma's Halol facility listed under USFDA import alert

Sun Pharma's Halol facility listed under USFDA import alert

Rediff.com8 Dec 2022

Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022. "We now wish to inform you that the company has received a communication from the USFDA stating that the facility has been listed under Import Alert," Sun Pharma said in a regulatory filing.

Ranbaxy loses exclusivity on heartburn drug in US

Ranbaxy loses exclusivity on heartburn drug in US

Rediff.com28 Jan 2015

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

'Trump Won't Target Indians'

'Trump Won't Target Indians'

Rediff.com30 Dec 2024

'Someone posts a job on LinkedIn and there are a thousand resumes in an hour? This is not the America IT professionals are used to.' 'Once they lose their job, it's impossible to get a job.'

Trump lists India among illicit drug-producing countries

Trump lists India among illicit drug-producing countries

Rediff.com17 Sep 2020

Trump said countries such as Afghanistan, India, The Bahamas, Belize, Burma, Colombia, Costa Rica and the Dominican Republic among others are a major drug transit or illicit drug producing nations.

HC seeks NCB's preliminary probe details against Sameer Wankhede

HC seeks NCB's preliminary probe details against Sameer Wankhede

Rediff.com18 Apr 2024

On Thursday, the bench, after perusing the plea copy, noted that Wankhede had approached the Central Administrative Tribunal, too, against the notices issued to him by the NCB.

FDA hikes fee for drug approvals, cuts unit inspection charge

FDA hikes fee for drug approvals, cuts unit inspection charge

Rediff.com5 Aug 2015

The fees for facility inspection of foreign companies have been reduced